FIGURE

Fig. 5

ID

ZDB-FIG-240620-48

Publication

Gauthier et al., 2024 - Therapeutic antibody engineering for efficient targeted degradation of membrane proteins in lysosomes

Other Figures

All Figure Page

Back to All Figure Page

Fig. 5

Antiproliferative effect of mAb and mAb-AMFA. Antiproliferative effect of CTX and CTX-AMFA in A431 (A) and HT-29 (B) cells. A431 and HT-29 cells were treated with 0.5?10 nM CTX or CTX-AMFA for 48 h and cell proliferation was analyzed by MTT assay. Results are presented as the percentage � SD of living cells compared to control (n=2). (C) Antiproliferative effect of CTX and CTX-AMFA in the presence of EGF. HeLa cells were treated with 0.5?10 nM CTX or CTX-AMFA in the presence of 200 ng/mL EGF for 48 h (n=3). (D) Antiproliferative effect of TRZ or TRZ-AMFA in the presence of EGF. ZR-75?1 cells were treated with 1?50 nM TRZ or TRZ-AMFA in the presence of 200 ng/mL EGF for 72 h (n=2). Cell proliferation was analyzed by MTT assay. Data are expressed as the percentage � SD of living cells relatively to control cells treated with EGF. Student?s t-test: * p value < 0.05; ** p value < 0.01.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.